» Articles » PMID: 32443594

Blood Eosinophils Subtypes and Their Survivability in Asthma Patients

Overview
Journal Cells
Publisher MDPI
Date 2020 May 24
PMID 32443594
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Eosinophils subtypes as lung-resident (rEOS) and inflammatory (iEOS) eosinophils are different in surface protein expression, functions, response to IL-5 and localization in lungs. rEOS- and iEOS-like eosinophils are found in blood; thus, we aimed to investigate their quantity and survivability in asthma patients. A total of 40 individuals were included: 10 steroid-free non-severe allergic asthma (AA), and 18 severe non-allergic eosinophilic asthma (SNEA) patients, the control group consisted of 12 healthy non-smoking subjects (HS). A bronchial challenge with allergen was performed for AA patients and HS. Blood eosinophils subtyping was completed with magnetic beads' conjugated antibodies against surface CD62L. Eosinophils adhesion to hTERT airway smooth muscle (ASM) cells was measured by evaluating their peroxidase activity and viability by annexin V and propidium iodide staining. We found that the predominant blood eosinophil subtype in AA patients was iEOS, while rEOS prevailed in SNEA patients (p < 0.05). Moreover, rEOS demonstrated higher adhesion intensity compared with iEOS in all investigated groups. Both eosinophils subtypes of SNEA patients had higher survivability over the AA group. However, iEOS survivability from AA and SNEA groups was higher compared with rEOS under standard conditions, when rEOS survivability increased after their incubation with ASM cells. Bronchial allergen challenge abolished the dominance of blood iEOS in AA patients and prolonged only iEOS survivability. Though the challenge did not affect the adhesion of any eosinophils subtypes, the direct dependence of rEOS and iEOS survivability on their interaction with ASM cells was revealed (p < 0.05). These findings provide the premise for eosinophils subtype-oriented asthma treatment.

Citing Articles

Eosinophils: old cells, new directions.

Sanchez Santos A, Socorro Avila I, Galvan Fernandez H, Cazorla Rivero S, Lemes Castellano A, Cabrera Lopez C Front Med (Lausanne). 2025; 11:1470381.

PMID: 39886455 PMC: 11780905. DOI: 10.3389/fmed.2024.1470381.


Serum T2-High Inflammation Mediators in Eosinophilic COPD.

Januskevicius A, Vasyle E, Rimkunas A, Palacionyte J, Kalinauskaite-Zukauske V, Malakauskas K Biomolecules. 2025; 14(12.

PMID: 39766355 PMC: 11674300. DOI: 10.3390/biom14121648.


Does Eosinophil Heterogeneity Translate into Functional Diversity? A Review of the Evolving Paradigm of Eosinophil Heterogeneity in Asthma.

Wilson G, Gautam S, Chupp G Biomedicines. 2024; 12(9).

PMID: 39335525 PMC: 11428232. DOI: 10.3390/biomedicines12092011.


Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthma.

Palacionyte J, Januskevicius A, Vasyle E, Rimkunas A, Miliauskas S, Malakauskas K Diagnostics (Basel). 2024; 14(13).

PMID: 39001236 PMC: 11240777. DOI: 10.3390/diagnostics14131345.


Exploring novel perspectives on eosinophilic inflammation in severe asthma.

Candia C, Ambrosino P, DAnna S, Motta A, Maniscalco M Biomark Med. 2024; 18(8):357-361.

PMID: 38623926 PMC: 11285210. DOI: 10.2217/bmm-2023-0801.


References
1.
Marichal T, Mesnil C, Bureau F . Homeostatic Eosinophils: Characteristics and Functions. Front Med (Lausanne). 2017; 4:101. PMC: 5504169. DOI: 10.3389/fmed.2017.00101. View

2.
Jung Y, Wen T, Mingler M, Caldwell J, Wang Y, Chaplin D . IL-1β in eosinophil-mediated small intestinal homeostasis and IgA production. Mucosal Immunol. 2015; 8(4):930-42. PMC: 4481137. DOI: 10.1038/mi.2014.123. View

3.
Abdala Valencia H, Loffredo L, Misharin A, Berdnikovs S . Phenotypic plasticity and targeting of Siglec-F(high) CD11c(low) eosinophils to the airway in a murine model of asthma. Allergy. 2015; 71(2):267-71. DOI: 10.1111/all.12776. View

4.
Bajoriuniene I, Malakauskas K, Lavinskiene S, Jeroch J, Sakalauskas R . Th17 response to Dermatophagoides pteronyssinus is related to late-phase airway and systemic inflammation in allergic asthma. Int Immunopharmacol. 2013; 17(4):1020-7. DOI: 10.1016/j.intimp.2013.10.004. View

5.
Abdala-Valencia H, Coden M, Chiarella S, Jacobsen E, Bochner B, Lee J . Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease. J Leukoc Biol. 2018; 104(1):95-108. PMC: 6013365. DOI: 10.1002/JLB.1MR1117-442RR. View